Effects of an evidence service on community-based AIDS service organizations' use of research evidence: A protocol for a randomized controlled trial

Wilson, Michael G.; Lavis, John N.; Grimshaw, Jeremy M.; Haynes, R. Brian; Bekele, Tsegaye; Rourke, Sean B.
January 2011
Implementation Science;2011, Vol. 6 Issue 1, p52
Academic Journal
Background: To support the use of research evidence by community-based organizations (CBOs) we have developed 'Synthesized HIV/AIDS Research Evidence' (SHARE), which is an evidence service for those working in the HIV sector. SHARE consists of several components: an online searchable database of HIV-relevant systematic reviews (retrievable based on a taxonomy of topics related to HIV/AIDS and open text search); periodic email updates; access to user-friendly summaries; and peer relevance assessments. Our objective is to evaluate whether this 'full serve' evidence service increases the use of research evidence by CBOs as compared to a 'self-serve' evidence service. Methods/design: We will conduct a two-arm randomized controlled trial (RCT), along with a follow-up qualitative process study to explore the findings in greater depth. All CBOs affiliated with Canadian AIDS Society (n = 120) will be invited to participate and will be randomized to receive either the 'full-serve' version of SHARE or the 'self-serve' version (a listing of relevant systematic reviews with links to records on PubMed and worksheets that help CBOs find and use research evidence) using a simple randomized design. All management and staff from each organization will be provided access to the version of SHARE that their organization is allocated to. The trial duration will be 10 months (two-month baseline period, six-month intervention period, and two month crossover period), the primary outcome measure will be the mean number of logins/month/organization (averaged across the number of users from each organization) between baseline and the end of the intervention period. The secondary outcome will be intention to use research evidence as measured by a survey administered to one key decision maker from each organization. For the qualitative study, one key organizational decision maker from 15 organizations in each trial arm (n = 30) will be purposively sampled. One-on-one semi-structured interviews will be conducted by telephone on their views about and their experiences with the evidence service they received, how helpful it was in their work, why it was helpful (or not helpful), what aspects were most and least helpful and why, and recommendations for next steps. Discussion: To our knowledge, this will be the first RCT to evaluate the effects of an evidence service specifically designed to support CBOs in finding and using research evidence. Trial registration: ClinicalTrials.gov: NCT01257724


Related Articles

  • ARC.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p171 

    An encyclopedia entry for "ARC," which stands for AIDS-related complex, is presented.

  • person with AIDS-related complex (PWARC):. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p177 

    An encyclopedia entry for the term "person with AIDS-related complex," which refers to an individual diagnosed with AIDS-related complex which is a precursor to the acquired immunodeficiency syndrome, is presented.

  • Optimism dominates AIDS vaccine confab. ROEHR, BOB // Windy City Times;10/6/2010, Vol. 26 Issue 1, p4 

    The article offers a look at the efforts launched to study HIV infection and AIDS vaccine.

  • Pneumocystis carinii Pneumonia as the First Presentation of HIV Infections in Patients Older Than... Jedlovsky, Veronika; Fleischman, Jean K. // AIDS Patient Care & STDs;May2000, Vol. 14 Issue 5, p247 

    Reports on pneumocystis carinii pneumonia as the first symptom of HIV infection among patients older than 50 years. Diagnosis of HIV infection; Factors that may cause delays in the diagnoses of HIV; HIV transmission risk factors; Treatment of HIV.

  • Response to treatment with the leukocyte-derived immunomodulator IMREG-1 in immunocompromised patients with AIDS-related complex. A multicenter, double-blind, placebo-controlled trial. Gottlieb, Marise S.; Zackin, Robert A.; Fiala, Milan; Henry, David H.; Marcel, Adrien J.; Combs, Kenneth L.; Vieira, Jeffrey; Liebman, Howard A.; Cone, Lawrence A.; Hillman, Kathryn S.; Gottlieb, A. Arthur; Gottlieb, M S; Zackin, R A; Fiala, M; Henry, D H; Marcel, A J; Combs, K L; Vieira, J; Liebman, H A; Cone, L A // Annals of Internal Medicine;7/15/91, Vol. 115 Issue 2, p84 

    Objective: To determine if a 6-month course of therapy with IMREG-1, a leukocyte-derived immunomodulator, slows disease progression in patients with AIDS-related complex.Design: Randomized, double-blind trial.Setting: Five academic- and three...

  • AIDS vaccines: progress and unmet challenges. Bolognesi, Dani P.; Bolognesi, D P // Annals of Internal Medicine;1/15/91, Vol. 114 Issue 2, p161 

    Editorial. Focuses on the progress of the development of HIV or AIDS vaccines. Issues ignored in developing a vaccine; Models used in clinical trials; Recommendations for the design of clinical trials.

  • Gender differences in HIV-1 diversity at time of infection. Michelle Long, E.; Martin, Harold L.; Kreiss, Joan K.; Rainwater, Stephanie M.J.; Lavreys, Ludo; Jackson, Denis J.; Rakwar, Joel; Mandaliya, Kishorchandra; Overbaugh, Julie // Nature Medicine;Jan2000, Vol. 6 Issue 1, p71 

    To develop an HIV-1 vaccine with global efficacy, it is important to identify and characterize the viruses that are transmitted, particularly to individuals living in areas of high incidence. Several studies have shown that virus from the blood of acutely infected adults was homogeneous, even...

  • Pediatric vaccine trials limited in U.S.  // AIDS Patient Care & STDs;Apr96, Vol. 10 Issue 2, p134 

    Focuses on the clinical trials for vaccines to prevent AIDS mother-child transmission in the United States. Transmission rate; Comments from Ross McKinney, the clinical director of Duke University's AIDS Clinical Trial Unit.

  • Clinically Correct? AIDS Education in Ontario in the 1980s and 1990s. Lenskyj, Helen Jefferson // Canadian Bulletin of Medical History;2007, Vol. 24 Issue 2, p403 

    This paper reviews AIDS prevention initiatives in Canada and the United States in the 1980s and 1990s, and presents a content analysis of print materials used in Ontario during this period. Problems in public health publications included biased approaches, inaccessible or clinical language,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics